Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.
Oncotarget
; 8(61): 104182-104192, 2017 Nov 28.
Article
in En
| MEDLINE
| ID: mdl-29262631
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncotarget
Year:
2017
Type:
Article
Affiliation country:
United States